I. Introduction Financial markets have grown rapidly over
the past decade, and innovations in financial instruments have facilitated
the structuring of cash flows and allocation of risk among creditors,
borrowers, and investors in more efficient ways. Financial derivatives
for market and credit risk, asset-backed securities with customized
cash flow features, specialized financial conduits that manage pools
of assets and other types of structured finance transactions serve
important business purposes, such as diversifying risks, allocating
cash flows, and reducing cost of capital. As a result, structured
finance transactions now are an essential part of U.S. and international
capital markets. Financial institutions have played and continue to
play an active and important role in the development of structured
finance products and markets, including the market for the more complex
variations of structured finance products.
When a financial institution participates in a complex
structured finance transaction (CSFT), it bears the usual market,
credit, and operational risks associated with the transaction. In
some circumstances, a financial institution also may face heightened
legal or reputational risks due to its involvement in a CSFT. For
example, in some circumstances, a financial institution may face heightened
legal or reputational risk if a customer’s regulatory, tax, or accounting
treatment for a CSFT, or disclosures to investors concerning the CSFT
in the customer’s public filings or financial statements, do not comply
with applicable laws, regulations, or accounting principles. In deed,
in some instances, CSFTs have been used to misrepresent a customer’s
financial condition to investors, regulatory authorities, and others.
In these situations, investors have been harmed, and financial institutions
have incurred significant legal and reputational exposure. In addition
to legal risk, reputational risk poses a significant threat to financial
institutions because the nature of their business requires them to
maintain the confidence of customers, creditors, and the general marketplace.
The Office of the Comptroller of the Currency, the Office
of Thrift Supervision, the Board of Governors of the Federal Reserve
System, the Federal Deposit Insurance Corporation, and the Securities
and Exchange Commission (the agencies) have long expected financial
institutions to develop and maintain robust control infrastructures
that enable them to identify, evaluate, and address the risks associated
with their business activities. Financial institutions also must conduct
their activities in accordance with applicable statutes and regulations.
II. Scope and Purpose of Statement The agencies are issuing this statement
to describe the types of risk-management principles that we believe
may help a financial institution to identify CSFTs that may pose heightened
legal or reputational risks to the institution (elevated-risk CSFTs)
and to evaluate, manage, and address these risks within the institution’s
internal control framework.
Structured finance transactions encompass a broad array
of products with varying levels of complexity. Most structured finance
transactions, such as standard public mortgage-backed securities transactions,
public securitizations of retail credit cards, asset-backed commercial
paper conduit transactions, and hedging-type transactions involving
“plain vanilla” derivatives and collateralized loan obligations, are
familiar to participants in the financial markets, and these vehicles
have a well-established track record. These transactions typically would not be considered CSFTs for the purpose of
this statement.
Because this statement focuses on sound practices related
to CSFTs that may create heightened legal or reputational risks—transactions
that typically are conducted by a limited number of large financial
institutions—it will not affect or apply to the vast majority of financial
institutions, including most small institutions. As in all cases,
a financial institution should tailor its internal controls so that
they are appropriate in light of the nature, scope, complexity, and
risks of its activities. Thus, for example, an institution that is
actively involved in structuring and offering CSFTs that may create
heightened legal or reputational risk for the institution should have
a more formalized and detailed control framework than an institution
that participates in these types of transactions less frequently.
The internal controls and procedures discussed in this statement are
not all-inclusive, and, in appropriate circumstances, an institution
may find that other controls, policies, or procedures are appropriate
in light of its particular CSFT activities.
Because many of the core elements of an effective control
infrastructure are the same regardless of the business line involved,
this statement draws heavily on controls and procedures that the agencies
previously have found to be effective in assisting a financial institution
to manage and control risks and identifies ways in which these controls
and procedures can be effectively applied to elevated-risk CSFTs.
Although this statement highlights some of the most significant risks
associated with elevated-risk CSFTs, it is not intended to present
a full exposition of all risks associated with these transactions.
Financial institutions are encouraged to refer to other supervisory
guidance prepared by the agencies for further information concerning
market, credit, operational, legal, and reputational risks as well
as internal audit and other appropriate internal controls.
This statement does not create any
private rights of action, and does not alter or expand the legal duties
and obligations that a financial institution may have to a customer,
its shareholders, or other third parties under applicable law. At
the same time, adherence to the principles discussed in this statement
would not necessarily insulate a financial institution from regulatory
action or any liability the institution may have to third parties
under applicable law.
III. Identification
and Review of Elevated-Risk Complex Structured Finance Transactions A financial institution that engages in
CSFTs should maintain a set of formal, written, firm-wide policies
and procedures that are designed to allow the institution to identify,
evaluate, assess, document, and control the full range of credit,
market, operational, legal, and reputational risks associated with
these transactions. These policies may be developed specifically for
CSFTs or included in the set of broader policies governing the institution
generally. A financial institution operating in foreign jurisdictions
may tailor its policies and procedures as appropriate to account for,
and comply with, the applicable laws, regulations and standards of
those jurisdictions.
A financial institution’s policies and procedures should
establish a clear framework for the review and approval of individual
CSFTs. These policies and procedures should set forth the responsibilities
of the personnel involved in the origination, structuring, trading,
review, approval, documentation, verification, and execution of CSFTs.
Financial institutions may find it helpful to incorporate the review
of new CSFTs into their existing new product policies. In this regard,
a financial institution should define what constitutes a “new” complex
structured finance product and establish a control process for the
approval of such new products. In determining whether a CSFT is new,
a financial institution may consider a variety of factors, including
whether it contains structural or pricing variations from existing
products, whether the product is targeted at a new class of customers,
whether it is designed to address a new need of customers, whether
it raises significant new legal, compliance, or regulatory issues,
and whether it or the manner in which it would be offered would materially
deviate from standard market practices. An institution’s policies
should require new complex structured finance products
to receive the approval of all relevant control areas that are independent
of the profit center before the product is offered to customers.
A. Identifying Elevated-Risk CSFTs As part of its transaction and new-product approval
controls, a financial institution should establish and maintain policies,
procedures, and systems to identify elevated-risk CSFTs. Because of
the potential risks they present to the institution, transactions
or new products identified as elevated-risk CSFTs should be subject
to heightened reviews during the institution’s transaction or new-product
approval processes. Examples of transactions that an institution may
determine warrant this additional scrutiny are those that (either
individually or collectively) appear to the institution during the
ordinary course of its transaction approval or new-product approval
process to—
- lack economic substance or business purpose;
- be designed or used primarily for questionable accounting,
regulatory, or tax objectives, particularly when the transactions
are executed at year-end or at the end of a reporting period for the
customer;
- raise concerns that the client will report or disclose
the transaction in its public filings or financial statements in a
manner that is materially misleading or inconsistent with the substance
of the transaction or applicable regulatory or accounting requirements;
- involve circular transfers of risk (either between
the financial institution and the customer or between the customer
and other related parties) that lack economic substance or business
purpose;
- involve oral or undocumented agreements that, when
taken into account, would have a material impact on the regulatory,
tax, or accounting treatment of the related transaction, or the client’s
disclosure obligations;
- have material economic terms that are inconsistent
with market norms (e.g., deep “in the money” options or historic rate
rollovers); or
- provide the financial institution with compensation
that appears substantially disproportionate to the services provided
or investment made by the financial institution or to the credit,
market, or operational risk assumed by the institution.
The examples listed previously are provided for illustrative
purposes only, and the policies and procedures established by financial
institutions may differ in how they seek to identify elevated-risk
CSFTs. The goal of each institution’s policies and procedures, however,
should remain the same—to identify those CSFTs that warrant additional
scrutiny in the transaction or new-product approval process due to
concerns regarding legal or reputational risks.
Financial institutions that structure or market,
act as an advisor to a customer regarding, or otherwise play a substantial
role in a transaction may have more information concerning the customer’s
business purpose for the transaction and any special accounting, tax,
or financial-disclosure issues raised by the transaction than institutions
that play a more limited role. Thus, the ability of a financial institution
to identify the risks associated with an elevated-risk CSFT may differ
depending on its role.
B. Due Diligence,
Approval and Documentation Process for Elevated-Risk CSFTs Having developed a process to identify elevated-risk
CSFTs, a financial institution should implement policies and procedures
to conduct a heightened level of due diligence for these transactions.
The financial institution should design these policies and procedures
to allow personnel at an appropriate level to understand and evaluate
the potential legal or reputational risks presented by the transaction
to the institution and to manage and address any heightened legal
or reputational risks ultimately found to exist with the transaction.
Due Diligence If a CSFT is identified as an elevated-risk CSFT,
the institution should carefully evaluate and take appropriate steps
to address the risks presented by the transaction with a particular
focus on those issues identified as potentially creating heightened
levels of legal or reputational risk for the institution. In general,
a financial institution should conduct the level and amount of due
diligence for an elevated-risk CSFT that is commensurate with the
level of risks identified. A financial institution that structures
or markets an elevated-risk CSFT to a customer, or that acts as an
advisor to a customer or investors concerning an elevated-risk CSFT,
may have additional responsibilities under the federal securities
laws, the Internal Revenue Code, state fiduciary laws, or other laws
or regulations and, thus, may have greater legal- and reputational-risk
exposure with respect to an elevated-risk CSFT than a financial institution
that acts only as a counterparty for the transaction. Accordingly,
a financial institution may need to exercise a higher degree of care
in conducting its due diligence when the institution structures or
markets an elevated-risk CSFT or acts as an advisor concerning such
a transaction than when the institution plays a more limited role
in the transaction.
To appropriately understand and evaluate the potential
legal and reputational risks associated with an elevated-risk CSFT
that a financial institution has identified, the institution may find
it useful or necessary to obtain additional information from the customer
or to obtain specialized advice from qualified in-house or outside
accounting, tax, legal, or other professionals. As with any transaction,
an institution should obtain satisfactory responses to its material
questions and concerns prior to consummation of a transaction.
In conducting its due diligence for an elevated-risk CSFT,
a financial institution should independently analyze the potential
risks to the institution from both the transaction and the institution’s
overall relationship with the customer. Institutions should not conclude
that a transaction identified as being an elevated-risk CSFT involves
minimal or manageable risks solely because another financial institution
will participate in the transaction or because of the size or sophistication
of the customer or counterparty. Moreover, a financial institution
should carefully consider whether it would be appropriate to rely
on opinions or analyses prepared by or for the customer concerning
any significant accounting, tax, or legal issues associated with an
elevated-risk CSFT.
Approval
Process A financial institution’s policies
and procedures should provide that CSFTs identified as having elevated
legal or reputational risk are reviewed and approved by appropriate
levels of control and management personnel. The designated approval
process for such CSFTs should include representatives from the relevant
business line(s) and/or client management, as well as from appropriate
control areas that are independent of the business line(s) involved
in the transaction. The personnel responsible for approving an elevated-risk
CSFT on behalf of a financial institution should have sufficient experience,
training, and stature within the organization to evaluate the legal
and reputational risks, as well as the credit, market, and operational
risks to the institution.
The institution’s control framework should have procedures
to deliver the necessary or appropriate information to the personnel
responsible for reviewing or approving an elevated-risk CSFT to allow
them to properly perform their duties. Such information may include,
for example, the material terms of the transaction, a summary of the
institution’s relationship with the customer, and a discussion of
the significant legal, reputational, credit, market and operational
risks presented by the transaction. Some institutions have established
a senior management committee that is designed to involve experienced
business executives and senior representatives from all of the relevant
control functions within the financial institution (including such
groups as independent risk management, tax, accounting, policy, legal,
compliance, and financial control) in the oversight and approval of
those elevated-risk CSFTs that are identified by the institution’s
personnel as requiring senior management review and approval due to
the potential risks associated with the transactions. While this type
of management committee may not be appropriate for all financial institutions,
a financial institution should establish processes that assist the
institution in consistently managing the review and approval of elevated-risk
CSFTs on a firm-wide basis.
If, after evaluating an elevated-risk CSFT, the financial
institution determines that its participation in the CSFT would create
significant legal or reputational risks for the institution, the institution
should take appropriate steps to address those risks. Such actions
may include declining to participate in the transaction, or conditioning
its participation upon the receipt of representations or assurances
from the customer that reasonably address the heightened legal or
reputational risks presented by the transaction. Any representations
or assurances provided by a customer should be obtained before a transaction
is executed and be received from, or approved by, an appropriate level
of the customer’s management. A financial institution should decline
to participate in an elevated-risk CSFT if, after conducting appropriate
due diligence and taking appropriate steps to address the risks from
the transaction, the institution determines that the transaction presents
unacceptable risk to the institution or would result in a violation
of applicable laws, regulations, or accounting principles.
Documentation The documentation that financial institutions use to support CSFTs
is often highly customized for individual transactions and negotiated
with the customer. Careful generation, collection, and retention of
documents associated with elevated-risk CSFTs are important control
mechanisms that may help an institution monitor and manage the legal,
reputational, operational, market, and credit risks associated with
the transactions. In addition, sound documentation practices may help
reduce unwarranted exposure to the financial institution’s reputation.
A financial institution should create and collect sufficient
documentation to allow the institution to—
- document the material terms of the transaction;
- enforce the material obligations of the counterparties;
- confirm that the institution has provided the customer
any disclosures concerning the transaction that the institution is
otherwise required to provide; and
- verify that the institution’s policies and procedures
are being followed and allow the internal audit function to monitor
compliance with those policies and procedures.
When an institution’s policies and procedures require
an elevated-risk CSFT to be submitted for approval to senior management,
the institution should maintain the transaction-related documentation
provided to senior management as well as other documentation, such
as minutes of the relevant senior management committee, that reflect
senior management’s approval (or disapproval) of the transaction,
any conditions imposed by senior management, and the factors considered
in taking such action. The institution should retain documents created
for elevated-risk CSFTs in accordance with its record retention policies
and procedures as well as applicable statutes and regulations.
C. Other Risk-Management Principles
for Elevated-Risk CSFTs General Business Ethics The board
and senior management of a financial institution also should establish
a “tone at the top” through both actions and formalized policies that
sends a strong message throughout the financial institution about
the importance of compliance with the law and overall good business
ethics. The board and senior management should strive to create a
firm-wide corporate culture that is sensitive to ethical or legal
issues as well as the potential risks to the financial institution
that may arise from unethical or illegal behavior. This kind of culture
coupled with appropriate procedures should reinforce business-line
ownership of risk identification, and encourage personnel
to move ethical or legal concerns regarding elevated-risk CSFTs to
appropriate levels of management. In appropriate circumstances, financial
institutions may also need to consider implementing mechanisms to
protect personnel by permitting the confidential disclosure of concerns.
As in other areas of financial institution management, compensation
and incentive plans should be structured, in the context of elevated-risk
CSFTs, so that they provide personnel with appropriate incentives
to have due regard for the legal-, ethical-, and reputational-risk
interests of the institution.
Reporting A financial institution’s
policies and procedures should provide for the appropriate levels
of management and the board of directors to receive sufficient information
and reports concerning the institution’s elevated-risk CSFTs to perform
their oversight functions.
Monitoring Compliance with Internal Policies and Procedures The events of recent years evidence the need for
an effective oversight and review program for elevated-risk CSFTs.
A financial institution’s program should provide for periodic independent
reviews of its CSFT activities to verify and monitor that its policies
and controls relating to elevated-risk CSFTs are being implemented
effectively and that elevated-risk CSFTs are accurately identified
and received proper approvals. These independent reviews should be
performed by appropriately qualified audit, compliance, or other personnel
in a manner consistent with the institution’s overall framework for
compliance monitoring, which should include consideration of issues
such as the independence of reviewing personnel from the business
line. Such monitoring may include more frequent assessments of the
risk arising from elevated-risk CSFTs, both individually and within
the context of the overall customer relationship, and the results
of this monitoring should be provided to an appropriate level of management
in the financial institution.
Audit The internal audit department
of any financial institution is integral to its defense against fraud,
unauthorized risk taking and damage to the financial institution’s
reputation. The internal audit department of a financial institution
should regularly audit the financial institution’s adherence to its
own control procedures relating to elevated-risk CSFTs, and further
assess the adequacy of its policies and procedures related to elevated-risk
CSFTs. Internal audit should periodically validate that business lines
and individual employees are complying with the financial institution’s
standards for elevated-risk CSFTs and appropriately identifying any
exceptions. This validation should include transaction testing for
elevated-risk CSFTs.
Training An institution should identify relevant
personnel who may need specialized training regarding CSFTs to be
able to effectively perform their oversight and review responsibilities.
Appropriate training on the financial institution’s policies and procedures
for handling elevated-risk CSFTs is critical. Financial institution
personnel involved in CSFTs should be familiar with the institution’s
policies and procedures concerning elevated-risk CSFTs, including
the processes established by the institution for identification and
approval of elevated-risk CSFTs and new complex structured finance
products and for the elevation of concerns regarding transactions
or products to appropriate levels of management. Financial institution
personnel involved in CSFTs should be trained to identify and properly
handle elevated-risk CSFTs that may result in a violation of law.
IV. Conclusion Structured finance products have become an essential and
important part of the U.S. and international capital markets, and
financial institutions have played an important role in the development
of structured finance markets. In some instances, however, CSFTs have
been used to misrepresent a customer’s financial
condition
to investors and others, and financial institutions involved in these
transactions have sustained significant legal and reputational harm.
In light of the potential legal and reputational risks associated
with CSFTs, a financial institution should have effective risk-management
and internal control systems that are designed to allow the institution
to identify elevated-risk CSFTs, to evaluate, manage, and address
the risks arising from such transactions, and to conduct those activities
in compliance with applicable law.
Interagency
statement of Jan. 11, 2007.